Rachel Splinter
Angels for Change serves as Advising Member in ...

At Angels for Change, we are proud to participate in the important work of the End Drug Shortages Alliance — serving as both an EDSA member organization and advising partner in the Drug Resiliency & Transparency Pilot.

The initial phase of the pilot demonstrated a powerful truth: when leaders come together early through trusted, neutral governance, transparency delivers real planning value.

Angels for Change serves as Advising Member in the Drug Resiliency & Transparency Pilot
A4C News, Press Release
Rachel Splinter
Project PROTECT Milestone: Angels for Change ...

Angels for Change today announced that the Mark Cuban Cost Plus Drug Company has completed the Preparation and Protective phases of Project PROTECT for Carboplatin Injection and Methotrexate Injection—two essential oncology medicines currently in nationwide shortage. This milestone strengthens onshore readiness and improves supply availability for patients across the United States.

Project PROTECT Milestone: Angels for Change and Mark Cuban Cost Plus Drug Company have Strengthened the U.S. Supply of Carboplatin & Methotrexate
A4C News
Rachel Splinter
Angels for Change Convenes First Ever SummitONE ...

New from Angels for Change: the launch of our Policy Lab.

The A4C Policy Lab brings together patients, clinicians, policymakers, and industry leaders to turn frontline experience into actionable policy solutions that address drug shortages at their root.

Last week on January 29th, 2026, Angels for Change convened a sold-out National Policy Lab on Capitol Hill in the historic Kennedy Caucus Room to tackle one of the most urgent issues in healthcare: the U.S. drug shortage crisis.

Angels for Change is translating patient harm into real-world policy solutions. This Policy Lab wasn’t a conference — it was a working session focused on collaboration, candor, and outcomes, with patients at the center of every solution.

Angels for Change Convenes First Ever SummitONE PolicyLAB to Drive Action on the U.S. Drug Shortage Crisis
A4C News
Rachel Splinter
2025 Year in Review

Angels for Change — 2025 Year in Review

From supporting patients through dozens of different shortage crisis to launching a first-of-its-kind oncology resiliency program to shaping national policy conversations, 2025 was a year of bold action and patient-driven progress.

Together with partners across healthcare, government, and industry, we:

  • Protected patients during critical drug shortages

  • Launched Project GOLD to proactively safeguard cancer care

  • Protected 4 addition essential medicines for the American people with Project PROTECT 

  • Elevated patient voices in policy and supply chain reform

  • Built momentum toward a more resilient medicine supply system

See how collaboration, transparency, and patient leadership are driving lasting change.

2025 Year in Review
In the News
Rachel Splinter
Project GOLD highlighted in USP Article

Nearly half of U.S. drug shortages, 47%, are tied to sudden spikes in demand, according to new data from the USP Medicine Supply Map. Angels for Change Project GOLD is highlighted in the article as a solution-oriented initiative that uses demand signals and buffer supply to help protect patients from shortages.

Project GOLD highlighted in USP Article

A4C News

White House Roundtable Invites Angels for Change as Healthcare Leader

White House Roundtable Invites Angels for Change as Healthcare Leader

Angels for Change’s (A4C) Chief Change Maker and Founder, Laura Bray, was invited to the White House for a roundtable on the current national pediatric and adult cancer drug shortage crisis. Bray was called on as one of the country’s top healthcare leaders to share her expertise, patient impact stories, and practical solutions to build a more resilient supply chain for all patients. Alongside Bray, were many of A4C’s Advisory Board members and End Drug Shortage Alliance (EDSA) leaders.

8,333 Bladder Cancer Patients a Year are not Receiving Optimal Care, Announces Angels for Change in Latest Report

Tampa, FL [February 21st, 2023]– Angels for Change announced the release of  white paper, "Implications of the National BCG Shortage", that describes the ongoing gap in supply and anticipated future demand of Bacillus Calmette-Guerin (BCG), an essential oncology medication used to treat patients with bladder cancer. 

Angels for Change Announces More Than Half a Million Life-Saving Treatments Accessed

Angels for Change Announces More Than Half a Million Life-Saving Treatments Accessed

Tampa, Florida– [November 30th, 2022]-- Angels for Change, a patient advocacy non-profit founded in Tampa, FL announces that they have supported patients in the access of half a million drug shortage treatments since April of this year.  Angels for Change is working to eradicate drug shortages after founder Laura Bray’s child faced three life-saving essential medicine shortages while fighting a pediatric cancer diagnosis. 

SHARE YOUR “WHY”

Every conversation, partnership, and shared story brings us closer to a future without drug shortages. At Angels for Change, we’re proud to march forth for patients everywhere.

SHARE YOUR STORY